Spero Therapeutics Newsroom

Spero Therapeutics (SPRO) Was Downgraded to a Hold Rating at Evercore ISI

TipRanksDec 23, 2024 08:10

Spero Therapeutics Analyst Ratings

BenzingaDec 20, 2024 19:41

Evercore ISI Group Downgrades Spero Therapeutics to In-Line, Maintains Price Target to $5

BenzingaDec 20, 2024 19:41

H.C. Wainwright Maintains Spero Therapeutics(SPRO.US) With Buy Rating, Maintains Target Price $5

Futu NewsDec 2, 2024 19:31

HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $5 Price Target

BenzingaDec 2, 2024 19:25

Buy Rating Reiterated for Spero Therapeutics Amid Promising Trial Progress and Strategic Partnership

TipRanksDec 2, 2024 19:23

TD Cowen Initiates Spero Therapeutics(SPRO.US) With Hold Rating

Futu NewsNov 19, 2024 16:36

Spero Therapeutics Cut to Hold From Buy by TD Cowen

Dow JonesNov 18, 2024 22:11

TD Cowen Downgrades Spero Therapeutics(SPRO.US) to Hold Rating

Futu NewsNov 18, 2024 11:31

Spero Therapeutics Analyst Ratings

BenzingaNov 15, 2024 22:32

H.C. Wainwright Maintains Spero Therapeutics(SPRO.US) With Buy Rating, Cuts Target Price to $5

Futu NewsNov 4, 2024 19:33

Spero Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesNov 4, 2024 19:23

Spero Therapeutics Analyst Ratings

BenzingaNov 4, 2024 19:14

TD Cowen Maintains Spero Therapeutics(SPRO.US) With Buy Rating

Futu NewsNov 1, 2024 20:31

Spero Therapeutics Analyst Ratings

BenzingaOct 3, 2024 19:52

H.C. Wainwright Maintains Spero Therapeutics(SPRO.US) With Buy Rating, Maintains Target Price $7

Futu NewsOct 3, 2024 18:35

Promising Clinical Developments Underpin Buy Rating for Spero Therapeutics

TipRanksOct 3, 2024 18:22

TD Cowen Upgrades Spero Therapeutics(SPRO.US) to Buy Rating

Futu NewsAug 6, 2024 20:34

Spero Therapeutics Analyst Ratings

BenzingaAug 6, 2024 19:14

HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $7 Price Target

BenzingaAug 6, 2024 19:14